Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Williamson Robert F III. Insider active across 1 company, notably Perspective Therapeutics, Inc.. Aggregated, 10 filings have been logged. Split: 10 buys · 0 sell. Total volume traded: €196k. Activity tracked since 18 December 2023. The latest transaction was filed on 12 November 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Williamson Robert F III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10,000 shares@ US$0.261.3% of flowCommon StockSEC:0001437749-23-034933:0
Canonical exit: 17 Mar 2024 (T+90)
10 of 10 declarations
About Williamson Robert F III
Williamson Robert F III is a Director of Perspective Therapeutics, Inc. (XNAS). Across 10 filings total, the 10 sampled filings, all acquisitions, cover the period from 2023-12-19 to 2025-11-14, with buy volume of EUR 196424 and no sell volume indicated.